Patent details

Basic Information

Publication number:

EP2827860

PCT Application Number:

PCT/EP/2013/055730

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137108510

PCT Publication Number:

WO/2013/139809

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF A PYRAZOLE DERIVATIVE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

French Title of Invention:

UTILISATION D'UN DÉRIVÉ DE PYRAZOLE DANS LE TRAITEMENT D'EXACERBATIONS AIGUES D'UNE MALADIE PULMONAIRE OBSTRUCTIVE CHRONIQUE

German Title of Invention:

VERWENDUNG EINES PYRAZOLDERIVATS ZUR BEHANDLUNG VON AKUTEN VERSCHLIMMERUNGEN BEI CHRONISCH OBSTRUKTIVER LUNGENERKRANKUNG

SPC Number:

Dates

Filing date:

19/03/2013

Grant date:

26/10/2016

EP Publication Date:

26/10/2016

PCT Publication Date:

26/09/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/01/2015

EP B1 Publication Date:

26/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/03/2013

 

 

Name:

Mereo BioPharma 1 Limited

Address:

1 Cavendish Place, London W1G 0QF, United Kingdom (GB)

Inventor

Name:

FORD Paul Andrew

Address:

United Kingdom (GB)

Priority

Priority Number:

201261613187

Priority Date:

20/03/2012

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/415;

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

13/03/2025

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages